These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 28100427)

  • 1. The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.
    Abrich VA; Ramakrishna H; Mehta A; Mookadam F; Srivathsan K
    Int J Cardiol; 2017 Apr; 232():243-246. PubMed ID: 28100427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QT interval prolongation and torsade de pointes induced by propofol and hypoalbuminemia.
    Irie T; Kaneko Y; Nakajima T; Saito A; Kurabayashi M
    Int Heart J; 2010; 51(5):365-6. PubMed ID: 20966611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
    Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
    Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N; Sugrue AM; Padmanabhan D; Kella D; DeSimone CV; Kapa S; Asirvatham SJ; Lee HC; Ackerman MJ; Noseworthy PA
    J Interv Card Electrophysiol; 2019 Mar; 54(2):189-196. PubMed ID: 30353374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of droperidol and ondansetron on dispersion of ventricular repolarization: A randomized double-blind clinical study in anesthetized adult patients.
    Agámez Medina GL; González-Arévalo A; Gómez-Arnau JI; García del Valle S; Rubio JA; Esteban E; Pérez E
    Rev Esp Anestesiol Reanim; 2015 Nov; 62(9):495-501. PubMed ID: 25887095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
    Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
    Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G; Carmel NN; Lotan D; Kremer A; Justo D
    Z Gerontol Geriatr; 2018 Jan; 51(1):41-47. PubMed ID: 27878411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repolarization characteristics and incidence of Torsades de Pointes in patients with acquired complete atrioventricular block.
    Bozkaya YT; Eroğlu Z; Kayikçioğlu M; Payzin S; Can LH; Kültürsay H; Hasdemir C
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():98-100. PubMed ID: 17584695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model.
    Lu HR; Gallacher DJ; Yan GX
    J Pharmacol Toxicol Methods; 2016; 81():151-60. PubMed ID: 27374776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Female gender as independent risk factor of torsades de pointes during acquired atrioventricular block.
    Chorin E; Hochstadt A; Viskin S; Rozovski U; Havakuk O; Baranchuk A; Enriquez A; Strasberg B; Guevara-Valdivia ME; Márquez MF; González-Pacheco H; Hasdemir C; Rosso R
    Heart Rhythm; 2017 Jan; 14(1):90-95. PubMed ID: 27650425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of transmural dispersion of repolarization in the genesis of drug-induced torsades de pointes.
    Antzelevitch C
    Heart Rhythm; 2005 Nov; 2(2 Suppl):S9-15. PubMed ID: 16253930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
    Bass AS; Hanson LA; Jackson TA
    J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
    Thomas SH; Behr ER
    Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragmented QRS is associated with torsades de pointes in patients with acquired long QT syndrome.
    Haraoka K; Morita H; Saito Y; Toh N; Miyoshi T; Nishii N; Nagase S; Nakamura K; Kohno K; Kusano KF; Kawaguchi K; Ohe T; Ito H
    Heart Rhythm; 2010 Dec; 7(12):1808-14. PubMed ID: 20837161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrocardiographic predictors of bradycardia-induced torsades de pointes in patients with acquired atrioventricular block.
    Cho MS; Nam GB; Kim YG; Hwang KW; Kim YR; Choi H; Kim SH; Rhee KS; Kim NJ; Kim JS; Kim J; Choi KJ; Kim YH
    Heart Rhythm; 2015 Mar; 12(3):498-505. PubMed ID: 25460857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting torsade de pointes in acquired long QT syndrome: optimal identification of critical QT interval prolongation.
    Chiladakis J; Kalogeropoulos A; Zagkli F; Koutsogiannis N; Chouchoulis K; Alexopoulos D
    Cardiology; 2012; 122(1):3-11. PubMed ID: 22626988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative QT interval prolongation in patients undergoing noncardiac surgery under general anesthesia.
    Nagele P; Pal S; Brown F; Blood J; Miller JP; Johnston J
    Anesthesiology; 2012 Aug; 117(2):321-8. PubMed ID: 22692379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.